Dr. Jose Maciel Larios completed a postdoctoral fellowship in a breast oncology/pharmacology lab at the University of Michigan. During his fellowship, Dr. Larios investigated molecular mechanisms of endocrine resistance in hormone receptor-positive breast cancer. He recapitulated newly published mutations in the estrogen receptor gene using breast cancer cell lines as pre-clinical models. Additionally, Dr. Larios also examined mechanisms of resistance to CDK4/6 inhibitors. He is a member of the American Society of Hematology and the American Society of Clinical Oncology. As a transplant hematologist, he would like to explore the role of the bone marrow microenvironment in leukemia progression.
Research and Clinical Interests:
Karmanos Cancer Institute's Bone Marrow or Stem Cell Program includes specialists who bring years of experience to the field of transplantation. Each patient receives personal attention from the Multidisciplinary Team, which is why our program is one of only a select group nationwide reporting some of the best survival outcomes for related and unrelated stem cell transplantation.
When you or a loved one comes to Karmanos Cancer Institute to see a medical oncologist, you can rest assured that our oncologists are specialized in their specific field of cancer.
Popular Mechanics It could be a mummy’s curse, but scientists believe it’s a toxic fungal spore that killed people entering tombs in the 1920s and 1970s. José Larios, M.D. , transplant hematologist and member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, reviewed a recent study that said this particular fungus could help in targeting and killing leukemia cells. He explained how long it could take to know if this fun...
The Barbara Ann Karmanos Cancer Institute welcomes José Larios, M.D. , transplant hematologist. Dr. Larios is a member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos. He specializes in treating leukemia and lymphoma blood cancers, including Hodgkin and non-Hodgkin lymphomas. He began seeing patients at the Karmanos Cancer Center in Detroit in August 2024. "Karmanos Cancer Institute is an NCI (National Cancer Institute)-Designated Comprehensive Can...